SMU Data Science Review
Abstract
Abstract. We evaluated the feasibility of using a blockchain technology to create a traceability solution for pharmaceutical drugs that would promote compliance with recent legislation. Counterfeit and other illegitimate pharmaceutical drugs threaten patient safety, drug efficacy, and patient trust. The purpose of the Drug Supply Chain Security Act (DSCSA) is to greatly reduce distribution of illegitimate drugs by requiring all pharmaceuticals to be serialized and traceable from the manufacturer through the supply chain to the dispenser. A software application to serialize and track pharmaceuticals must overcome numerous obstacles. In particular, the solution must provide a high degree of trust while also protecting privacy for manufacturers, distributors, and patients. This research will propose that a blockchain-enabled application will solve for many of the most challenging needs for this solution.
Recommended Citation
Scott, Tracie; Post, Armand L.; Quick, Johnny; and Rafiqi, Sohail
(2018)
"Evaluating Feasibility of Blockchain Application for DSCSA Compliance,"
SMU Data Science Review: Vol. 1:
No.
2, Article 4.
Available at:
https://scholar.smu.edu/datasciencereview/vol1/iss2/4
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial 4.0 License
Included in
Operations and Supply Chain Management Commons, Pharmaceutics and Drug Design Commons, Pharmacoeconomics and Pharmaceutical Economics Commons, Pharmacy Administration, Policy and Regulation Commons
